Monday, November 8, 2010

Stock Idea: NGL Fine-Chem

NGL Fine-chem Ltd is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. Company caters to various global companies to custom manufacture high quality pharmaceuticals with reliability and flexibility. Utilizing its expertise in complex multi-stage organic synthesis, company continues to expand their product portfolio with new products. Company has established a strong presence in global pharmaceutical companies with its commitment to competitive prices, delivery schedules, international quality standards and constant  technological upgradation. The Company was incorporated on December 18, 2981 as  Private Limited Company in the State of Maharashtra. The Company became a Deemed Limited Company by virtue of Section 43A of the Companies Act, 1956 on 29.12.1993 and the necessary alternation to the Certificate of Incorporation was duly btained from the Registrar of Companies, Maharashtra. The Company has deleted the restrictive clauses in the articles of association by passing a special resolution on  May 20,1994 and has become a Public Limited Company. The Company has got its registered office and factory at New Bombay. The Company was promoted by Mr. A.G.Lawande, Mr.R. J. Nachane joined Mr.A.G.Lawande for actively participating in the management of the company in 1989.
It has an equity base of Rs.3.09crore that is supported by reserve of around Rs.8crore leading to a book share value around Rs.22.10. The promoters hold 66.68%, non promoter corporate bodies hold 11.85% while the investing public holds 21.46% stake in the company. For FY10, it recorded net sales of Rs.28.02crore with net profit of Rs.2.71crore against net sales of Rs.24.63crore with net profit of Rs.1.68crore in FY09. (Net profit zoomed 61% on yearly basis). The FY10 EPS was Rs.4.36. At current level, the stock is available at a forward P/E multiple of just 5.5.
Target Rs. 45-50/- Short to Medium Term
Rs. 60-80/- Long Term
Source: Internet (Valuenotes by ProfitTrack)

No comments:


The information in this publication is provided by is intended for use for Readers & Traders . Every effort is made to provide accurate information, but cannot guarantee the accuracy of the information or of the market analysis. This is a newsletter and is for informational purposes only. It is not a solicitation or offer to buy or sell futures. There is a high risk of loss in trading futures. You should not trade with money that you cannot afford to lose. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this newsletter. The past performance of any trading system or methodology is not necessarily indicative of future results.

free counter